Galmed Pharmaceuticals (GLMD) Total Debt (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Total Debt of $355000.0 for Q1 2026, down 28.86% year-over-year from $499000.0 in Q1 2025, and down 57.84% quarter-over-quarter from $842000.0 in Q4 2025.
Galmed Pharmaceuticals (GLMD) Total Debt (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Total Debt history runs 14 years deep, the most recent figure standing at $355000.0 for Q1 2026.
- In Q1 2026, Total Debt fell 28.86% year-over-year to $355000.0; the TTM figure through Mar 2026 stood at $355000.0 (down 28.86% YoY), while the FY2025 annual figure was $842000.0, up 83.44% from the prior year.
- Total Debt for Q1 2026 stood at $355000.0, down from $842000.0 in the prior quarter.
- The five-year high for Total Debt was $1.2 million in Q3 2024, with the low at $351000.0 in Q2 2024.
- The 5-year median for Total Debt is $600000.0 (2023), against an average of $656375.0.
- The sharpest annual moves came in 2022 and 2025: Total Debt sank 53.59% in 2022, then jumped 199.72% in 2025.
- Galmed Pharmaceuticals' Total Debt stood at $534000.0 in 2022, then soared by 63.11% to $871000.0 in 2023, then sank by 47.3% to $459000.0 in 2024, then jumped by 83.44% to $842000.0 in 2025, then slumped by 57.84% to $355000.0 in 2026.
- Business Quant data shows GLMD's Total Debt at $355000.0 in Q1 2026, $842000.0 in Q4 2025, and $798000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 9.34 Bn |
| 10 | Galmed Pharmaceuticals | 2.34 Mn | -9.54 Mn | - | 355,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,000.00 |
| Dec 31, 2025 | 842,000.00 |
| Sep 30, 2025 | 798,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 499,000.00 |
| Dec 31, 2024 | 459,000.00 |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 351,000.00 |
| Mar 31, 2024 | 382,000.00 |
| Dec 31, 2023 | 871,000.00 |
| Sep 30, 2023 | 617,000.00 |
| Jun 30, 2023 | 583,000.00 |
| Mar 31, 2023 | 535,000.00 |
| Dec 31, 2022 | 534,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 812,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.33 Mn |